Happiness Biotech Gets Green Light to Sell Hand Sanitizer in Canada
Happiness Biotech Group Ltd. (Nasdaq: HAPP) announced Tuesday that it has received a Natural Product Number (NPN) license in Canada for its 75% alcohol disposable hand sanitizer.
The nutraceutical and dietary supplements producer said in a statement today that the first batch of 53,280 bottles was shipped this week. According to the company, the hand sanitizer met the criteria of safety, efficacy, and quality to be sold in Canada.
"We are very glad that our hand sanitizer can finally be exported to Canada. Although the first batch is only over 50,000 bottles, we believe this is a good start," Xuezhu Wang, the chief executive officer of Happiness, said in a statement today.
He added, "Meanwhile, 150,000 of our masks were exported to Canada in May and we received the second order of 200,000 pieces in June. We believe our receipt of the NPN license from Health Canada demonstrates quality of our products. In the future, we will continue to strive to export to more countries and regions."
In May, Happiness reported that sales of its alcohol disinfectant and disposable hand sanitizer have exceeded 9 million bottles as of April.
Happiness has also been active in attempting to develop a more affordable Covid-19 testing kit. Last month, it said it obtained the CE Certification for its testing kits—the samples have been shipped to countries including Uganda, Malaysia, and Canada.
Despite the development, Happiness is likely not ectastic about its stock market performance this year. Shares have plunged 71% year-to-date.
Based in Nanping, Happiness operates mainly through Fujian Happiness. Its product portfolio includes 32 types of nutraceutical and dietary supplements. The stock in Happiness inched 2% lower from Monday's close to $2.77 per American depositary share by midday Tuesday.
MDJM Gets Warning From Nasdaq for Failing the Minimum Public Holders Requirement
BeiGene Highlights Q2 Drug Approvals, Product Pipeline
S&P 500 Bulls Meet Unemployment Claims
Troubled Game Company The9 Hopes for Revival With New Capital
Tigermed Consulting Ends Hong Debut 13% Higher in Asia's Largest Healthcare Listing This Year
Jacobio Pharmaceuticals Aims to Raise $400 Million in Hong Kong